Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712 (Q34879367)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712 |
scientific article |
Statements
1 reference
Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712 (English)
1 reference
John C Byrd
1 reference
Nyla A Heerema
1 reference
Jennifer A Woyach
1 reference
John G Gribben
1 reference
Amy S Ruppert
1 reference
Kanti R Rai
1 reference
Bercedis L Peterson
1 reference
Vicki A Morrison
1 reference
14 February 2011
1 reference
1 reference
29
1 reference
10
1 reference
1349-1355
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference